bioRxivMicrobiologyPreprint
A biofilm activator MmtA1 modulates multi-drug resistance in mycobacteria
Abstract
When exposed to the antibiotic-induced stress, Mycobacterium species have the ability to survive by forming protective multicellular structures known as biofilms. However, the underlying mechanism of biofilm formation in response to antibiotics is not fully understood. In this study, we identified a transcriptional factor, MmtA1, which responds to the first-line anti-tuberculosis drug isoniazid and regulates genes involved in sugar and lipid transportation. This leads to increased biofilm formation and multi-drug resistance in M. smegmatis. These findings suggest that isoniazid may act as a molecular messenger, working in coordination with transcriptional regulatory factors to induce multidrug resistance under chemotherapy. ImportanceThis study elucidates a novel transcriptional regulatory mechanism by which Mycobacterium smegmatis develops multidrug resistance in response to the anti-tuberculosis drug isoniazid. By linking antibiotic stress to transcriptional regulation and metabolic adaptation, this work provides new insights into drug-induced tolerance in mycobacteria, suggesting antibiotic functional as inducer of biofilm formation, triggering a coordinated transcriptional response to enhance bacterial survival under antibiotic pressure.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rv0783c of Mycobacterium tuberculosis acts as a proton-motive force dependent multidrug efflux transporter involved in the efflux of structurally unrelated antibiotics and enhancing biofilm formation
Debleena Bhattacharyya, Debasmita Chatterjee, … Anindya Sundar Ghosh·Molecular MicrobiologyPeer-reviewed·Oct 30, 2026
- Microbicidal Mechanisms for Light-Activated Molecular Nanomachines in Mycobacterium smegmatis: A Model for Pathogenic Bacteria
Thushara Galbadage, Dongdong Liu, … Richard S. Gunasekera·OpenNanoPeer-reviewed·Feb 25, 2025
- Putative MFS transporter Rv1250 of Mycobacterium tuberculosis is involved in multidrug efflux activity
Debasmita Chatterjee, Ajit Ramesh Sawant, … Anindya Sundar Ghosh·bioRxiv·Aug 6, 2025
- Adaptation of Mycobacterium tuberculosis to biofilm growth is genetically linked to drug tolerance
J. P. Richards, W. Cai, … A. K. Ojha·bioRxiv·Jun 6, 2019
- Acetylation of isoniazid - a novel mechanism of isoniazid resistance in Mycobacterium tuberculosis
A. K B, A. Madhavan, … A. K. R·bioRxiv·Feb 10, 2020
- Network stress test reveals novel drug potentiators in Mycobacterium tuberculosis
Shuyi Ma, Robert Morrison, … David R. Sherman·bioRxiv·Sep 27, 2018